[Therapeutic effect of tiotropium bromide powder inhalation in patients with stable bronchiectasis]. 2010

Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
Department of Respiratory Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. myxiao2000@126.com

OBJECTIVE To observe the therapeutic effect of tiotropium bromide powder inhalation on stable bronchiectasis. METHODS Twenty-two patients with stable bronchiectasis received inhalation of totropium bromide powder at the daily dose of 18 microg, and on days 1 and 28, the patients were examined for forced expiratory volume in one second (FEVl), predicted value [FEVl(%)], forced expiratory volume (FEV), and FEVl/FVC. The symptom score and BODE index were also recorded. RESULTS After 1 month of inhalation therapy, the FEV1% of the patients showed a moderate increase but the increment was not statistically significant (t=-1.875, P>0.05); the symptom score and BODE index decreased significantly after the therapy (t=7.091, P<0.001; t=2.982, P<0.05). CONCLUSIONS Long-term inhalation of tiotropium bromide powder can improve the clinical symptoms and BODE index and enhance the exercise tolerance and quality of life of the patients with bronchiectasis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D001987 Bronchiectasis Persistent abnormal dilatation of the bronchi. Cylindrical Bronchiectasis,Cystic Bronchiectasis,Saccular Bronchiectasis,Varicose Bronchiectasis,Bronchiectases,Bronchiectasis, Cylindrical,Bronchiectasis, Cystic,Bronchiectasis, Saccular,Bronchiectasis, Varicose,Cylindrical Bronchiectases,Cystic Bronchiectases,Saccular Bronchiectases,Varicose Bronchiectases
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069447 Tiotropium Bromide A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. 7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide,BA 679 BR,BA-679 BR,Spiriva,Tiotropium,679 BR, BA,BA679 BR,BR, BA 679,Bromide, Tiotropium
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
April 1992, Allergy,
Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
January 2012, Drugs,
Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
February 2008, COPD,
Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
January 2021, Computational and mathematical methods in medicine,
Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
June 1999, American journal of respiratory and critical care medicine,
Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
November 1988, Arzneimittel-Forschung,
Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
June 2014, Hospital pharmacy,
Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
June 2019, Journal of aerosol medicine and pulmonary drug delivery,
Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
February 2023, Lung,
Xiao-ling Li, and Shao-xi Cai, and Hai-jin Zhao, and Li-min Dong, and Xiang-bo Shen, and Lai-yu Liu, and Guo-dong Hu
September 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Copied contents to your clipboard!